Neuropsychological Aspects of Substance Use Disorders

Informationen zum Autor Daniel N. Allen, PhD, is the Lincy Professor of Psychology at the University of Nevada Las Vegas, and President-Elect of the National Academy of Neuropsychology. He has more than 150 professional publications in the areas of neuropsychology, mental illness and substance use disorders. He is a fellow of APA division 40, the National Academy of Neuropsychology, and Western Psychological Association, and has been recognized with a number of awardsincluding the Nelson Butters Award and Early Career Award from the National Academy of Neuropsychology, as well as the Barrick Distinguished Scholar Award and Academic Advisor Award from the University of Nevada, Las Vegas. Steven Paul Woods, PsyD, is a clinical neuropsychologist and Professor of Psychiatry at University of California San Diego. His NIH-funded program of research focuses on the role of memory in the daily lives of persons living with HIV infection and addictions. Dr. Woods has over 125 publications and was the recipient of the 2007 Early Career Award for Contributions to Clinical Neuropsychology from the National Academy of Neuropsychology. Klappentext In Neuropsychological Aspects of Substance Use Disorders, internationally recognized experts provide clinicians with a translational overview of basic research and treatment findings regarding addictions, neuropsychological and neurological sequalae of the most common substances of abuse. Zusammenfassung In Neuropsychological Aspects of Substance Use Disorders, internationally recognized experts provide clinicians with a translational overview of basic research and treatment findings regarding addictions, neuropsychological and neurological sequalae of the most common substances of abuse. PREFACE TO THE NATIONAL ACADEMY OF NEUROPSYCHOLOGY SERIES ON EVIDENCE-BASED PRACTICES ; PREFACE TO THE THIRD VOLUME IN THE NATIONAL ACADEMY OF NEUROPSYCHOLOGY SERIES ON EVIDENCE-BASED PRACTICES ; CONTRIBUTORS ; CHAPTER 1: INTRODUCTION ; DANIEL ALLEN AND STEVEN PAUL WOODS ; CHAPTER 2: NEURAL SUBSTRATES OF DRUG ABUSE ; VERONICA BISAGNO AND JEAN LUD CADET ; CHAPTER 3: BEHAVIORAL AND NEURO-ECONOMIC APPROACHES TO ADDICTION ; DAVID P. JARMOLOWICZ, DEREK D. REED, AND WARREN BICKEL ; CHAPTER 4: GENETIC INFLUENCES ON ADDICTION ; AMANDA BARKLEY-LEVENSON AND JOHN CRABBE ; CHAPTER 5: TREATMENT OF ADDICTIONS AND EFFECTS OF NEUROPSYCHOLOGICAL IMPAIRMENT ; ON MECHANISMS OF BEHAVIOR CHANGE ; MARSHA BATES, JENNIFER F. BUCKMAN, AND JUSTINE C. BATES KRAKOFF ; CHAPTER 6: ALCOHOL USE DISORDERS: BRAIN AND BEHAVIORAL SEQUELAE ; ROSEMARY FAMA AND EDITH V. SULLIVAN ; CHAPTER 7: CANNABIS ; JORDAN CATTIE AND IGOR GRANT ; CHAPTER 8: NEUROPSYCHOLOGICAL SEQUELAE OF COCAINE DEPENDENCE ; ANTONIO VERDEJO GARCIA ; CHAPTER 9: NEUROPSYCHOLOGY OF METHAMPHETAMINE USE DISORDERS ; JENNIFER IUDICELLO, KHALIMA BOLDEN, STEFANIE R. GRIGLAK, AND STEVEN PAUL WOODS, ; CHAPTER 10: CLUB DRUGS ; JOHN E. FISK AND CATHERINE MONTGOMERY ; CHAPTER 11: OPIOIDS. ; OLGA RASS, REBECCA L. SCHACHT, CHERIE L. MARVEL, MIRIAM Z. MINTZER, ; CHAPTER 12: ADOLESCENT INHALANT MISUSE: NEUROPSYCHOLOGICAL AND NEUROBIOLOGICAL EFFECTS ; MICHAEL TAKAGI, DAN I. LUBMAN, SUSAN M. COTTON, AND MURAT YUCEL ; CHAPTER 13: NEUROPSYCHOLOGY OF SERIOUS MENTAL ILLNESS AND SUBSTANCE USE DISORDER COMORBIDITY ; DANIEL N. ALLEN, BERN G. LEE, AND NICHOLAS S. THALER ; CHAPTER 14: NEUROPSYCHOLOGY OF INFECTIOUS DISEASE AND SUBSTANCE USE DISORDERS ; JENNIFER M. LOFTIS, MARILYN HUCKANS, ERICA WEBER, AND STEVEN PAUL WOODS ; CHAPTER 15: SUBSTANCE ABUSE AND TRAUMATIC BRAIN INJURY ; TRESA ROEBUCK SPENCER, ELISABETH WILDE, AND ANGELLE SANDER ; CHAPTER 16: THE CONTRIBUTION OF NEUROPSYCHOLOGY TO FUNCTIONAL OUTCOMES IN SUBSTANCE USE DISORDERS ; J. COBB SCOTT, KAITLIN BLACKSTONE, AND THOMAS D. MARCOTTE ; CHAPTER 17: PRESCRIPTION DRUG ABUSE ; KAI-HONG JEREMY MAO, LAUREN N. BUCHHEIM, JASON P. CAPLAN ; CHAPTER 18: CNS RISK FACTORS FOR AND CONSEQUENCES OF ADOLESCENT SUBSTANCE USE ON...

Klappentext

In Neuropsychological Aspects of Substance Use Disorders, internationally recognized experts provide clinicians with a translational overview of basic research and treatment findings regarding addictions, neuropsychological and neurological sequalae of the most common substances of abuse.

Inhalt

PREFACE TO THE NATIONAL ACADEMY OF NEUROPSYCHOLOGY SERIES ON EVIDENCE-BASED PRACTICES ; PREFACE TO THE THIRD VOLUME IN THE NATIONAL ACADEMY OF NEUROPSYCHOLOGY SERIES ON EVIDENCE-BASED PRACTICES ; CONTRIBUTORS ; CHAPTER 1: INTRODUCTION ; DANIEL ALLEN AND STEVEN PAUL WOODS ; CHAPTER 2: NEURAL SUBSTRATES OF DRUG ABUSE ; VERONICA BISAGNO AND JEAN LUD CADET ; CHAPTER 3: BEHAVIORAL AND NEURO-ECONOMIC APPROACHES TO ADDICTION ; DAVID P. JARMOLOWICZ, DEREK D. REED, AND WARREN BICKEL ; CHAPTER 4: GENETIC INFLUENCES ON ADDICTION ; AMANDA BARKLEY-LEVENSON AND JOHN CRABBE ; CHAPTER 5: TREATMENT OF ADDICTIONS AND EFFECTS OF NEUROPSYCHOLOGICAL IMPAIRMENT ; ON MECHANISMS OF BEHAVIOR CHANGE ; MARSHA BATES, JENNIFER F. BUCKMAN, AND JUSTINE C. BATES KRAKOFF ; CHAPTER 6: ALCOHOL USE DISORDERS: BRAIN AND BEHAVIORAL SEQUELAE ; ROSEMARY FAMA AND EDITH V. SULLIVAN ; CHAPTER 7: CANNABIS ; JORDAN CATTIE AND IGOR GRANT ; CHAPTER 8: NEUROPSYCHOLOGICAL SEQUELAE OF COCAINE DEPENDENCE ; ANTONIO VERDEJO GARCIA ; CHAPTER 9: NEUROPSYCHOLOGY OF METHAMPHETAMINE USE DISORDERS ; JENNIFER IUDICELLO, KHALIMA BOLDEN, STEFANIE R. GRIGLAK, AND STEVEN PAUL WOODS, ; CHAPTER 10: CLUB DRUGS ; JOHN E. FISK AND CATHERINE MONTGOMERY ; CHAPTER 11: OPIOIDS. ; OLGA RASS, REBECCA L. SCHACHT, CHERIE L. MARVEL, MIRIAM Z. MINTZER, ; CHAPTER 12: ADOLESCENT INHALANT MISUSE: NEUROPSYCHOLOGICAL AND NEUROBIOLOGICAL EFFECTS ; MICHAEL TAKAGI, DAN I. LUBMAN, SUSAN M. COTTON, AND MURAT YUCEL ; CHAPTER 13: NEUROPSYCHOLOGY OF SERIOUS MENTAL ILLNESS AND SUBSTANCE USE DISORDER COMORBIDITY ; DANIEL N. ALLEN, BERN G. LEE, AND NICHOLAS S. THALER ; CHAPTER 14: NEUROPSYCHOLOGY OF INFECTIOUS DISEASE AND SUBSTANCE USE DISORDERS ; JENNIFER M. LOFTIS, MARILYN HUCKANS, ERICA WEBER, AND STEVEN PAUL WOODS ; CHAPTER 15: SUBSTANCE ABUSE AND TRAUMATIC BRAIN INJURY ; TRESA ROEBUCK SPENCER, ELISABETH WILDE, AND ANGELLE SANDER ; CHAPTER 16: THE CONTRIBUTION OF NEUROPSYCHOLOGY TO FUNCTIONAL OUTCOMES IN SUBSTANCE USE DISORDERS ; J. COBB SCOTT, KAITLIN BLACKSTONE, AND THOMAS D. MARCOTTE ; CHAPTER 17: PRESCRIPTION DRUG ABUSE ; KAI-HONG JEREMY MAO, LAUREN N. BUCHHEIM, JASON P. CAPLAN ; CHAPTER 18: CNS RISK FACTORS FOR AND CONSEQUENCES OF ADOLESCENT SUBSTANCE USE ON BRAIN STRUCTURE AND FUNCTION ; SUSAN TAPERT, LOTTE BERKE, NORMA CASTRO, AND SUNITA BAVA ; INDEX